300110 华仁药业
已收盘 08-28 15:00:00
资讯
新帖
简况
华仁药业(300110)8月20日股东户数3.99万户,较上期增加1.01%
证券之星 · 08-27 18:12
华仁药业(300110)8月20日股东户数3.99万户,较上期增加1.01%
股市必读:华仁药业新发布《第八届董事会第十六次会议决议公告》
证券之星 · 08-27 07:58
股市必读:华仁药业新发布《第八届董事会第十六次会议决议公告》
华仁药业:截至2026年8月20日,公司股东总户数约为3.99万户
证券之星 · 08-25
华仁药业:截至2026年8月20日,公司股东总户数约为3.99万户
股市必读:华仁药业(300110)8月13日董秘有最新回复
证券之星 · 08-14
股市必读:华仁药业(300110)8月13日董秘有最新回复
华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户
证券之星 · 08-13
华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户
股市必读:华仁药业(300110)8月5日董秘有最新回复
证券之星 · 08-06
股市必读:华仁药业(300110)8月5日董秘有最新回复
华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户
证券之星 · 08-05
华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户
股市必读:华仁药业新发布《关于收到青岛证监局对公司采取责令改正监管措施决定的公告》
证券之星 · 08-03
股市必读:华仁药业新发布《关于收到青岛证监局对公司采取责令改正监管措施决定的公告》
华仁药业被责令改正,涉内控等违规
蓝鲸财经 · 07-31
华仁药业被责令改正,涉内控等违规
华仁药业的“双重困局”:旧账未清、新诉重审,资产缩水近半暴露内控危机
新浪证券 · 07-31
华仁药业的“双重困局”:旧账未清、新诉重审,资产缩水近半暴露内控危机
华仁药业:上半年业绩情况请关注公司计划于2026年8月27日披露的2026年半年度报告
证券之星 · 07-29
华仁药业:上半年业绩情况请关注公司计划于2026年8月27日披露的2026年半年度报告
股市必读:华仁药业(300110)7月24日董秘有最新回复
证券之星 · 07-27
股市必读:华仁药业(300110)7月24日董秘有最新回复
华仁药业:持续推进相关应收款项追偿
证券之星 · 07-24
华仁药业:持续推进相关应收款项追偿
华仁药业:积极布局饮料、化妆品、健康饮品等大健康产品线
证券之星 · 07-24
华仁药业:积极布局饮料、化妆品、健康饮品等大健康产品线
华仁药业:截至2026年7月20日,公司股东总户数约为3.96万户
证券之星 · 07-23
华仁药业:截至2026年7月20日,公司股东总户数约为3.96万户
华仁药业:公司将基于最大化挽回损失的原则,持续积极跟进债务化解进度
证券之星 · 07-23
华仁药业:公司将基于最大化挽回损失的原则,持续积极跟进债务化解进度
华仁药业:已将常态化梳理应收款项、加快应收处置回款、持续优化资产结构等纳入重点工作安排
证券之星 · 07-16
华仁药业:已将常态化梳理应收款项、加快应收处置回款、持续优化资产结构等纳入重点工作安排
华仁药业(300110)披露重大诉讼进展公告,7月15日股价上涨1.81%
证券之星 · 07-15
华仁药业(300110)披露重大诉讼进展公告,7月15日股价上涨1.81%
华仁药业:关于股份回购计划
证券之星 · 07-14
华仁药业:关于股份回购计划
华仁药业:截至2026年7月10日,公司股东总户数约为3.90万户
证券之星 · 07-14
华仁药业:截至2026年7月10日,公司股东总户数约为3.90万户
加载更多
公司概况
公司名称:
华仁药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-08-25
主营业务:
华仁药业股份有限公司的主营业务是原料药、制剂、医疗器械、医用包材、大健康产品的研发、生产、销售。公司的主要产品是基础输液、腹膜透析液、小容量注射剂、治疗性输液、片剂、胶囊剂、散剂、颗粒剂、医疗器械、配套医用包材、大健康产品、原料药。公司先后获得“全国AAA级信用企业”、“国家知识产权优势/示范企业”、“中国化学制药行业工业企业综合实力百强”、“中国医药工业百强”、“山东省质量管理奖”、“山东省高端品牌培育企业”、“‘品质鲁药’建设示范企业”等系列荣誉。
发行价格:
13.99
{"stockData":{"symbol":"300110","market":"SZ","secType":"STK","nameCN":"华仁药业","latestPrice":2.96,"timestamp":1787900634000,"preClose":2.92,"halted":0,"volume":38129787,"delay":0,"changeRate":0.0137,"floatShares":1181000000,"shares":1182000000,"eps":-0.399,"marketStatus":"已收盘","change":0.04,"latestTime":"08-28 15:00:00","open":2.91,"high":3,"low":2.87,"amount":113000000,"amplitude":0.0445,"askPrice":2.97,"askSize":6364,"bidPrice":2.96,"bidSize":1478,"shortable":0,"etf":0,"ttmEps":-0.399,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":5,"adr":0,"adjPreClose":2.92,"symbolType":"stock","openAndCloseTimeList":[[1787880600000,1787887800000],[1787893200000,1787900400000]],"highLimit":3.21,"lowLimit":2.63,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1182212982,"isCdr":false,"pbRate":3.98,"roa":"--","roe":"3.35%","epsLYR":-0.3916,"committee":-0.524774,"marketValue":3499000000,"turnoverRate":0.0323,"status":0,"floatMarketCap":3497000000},"requestUrl":"/m/hq/s/300110","defaultTab":"news","newsList":[{"id":"2662870345","title":"华仁药业(300110)8月20日股东户数3.99万户,较上期增加1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662870345","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662870345?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:12","pubTimestamp":1787825549,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2026年8月20日公司股东户数为3.99万户,较8月10日增加400.0户,增幅为1.01%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至8月20日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年8月10日至2026年8月20日,华仁药业区间涨幅为5.34%,在此期间股东户数增加400.0户,增幅为1.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662723052","title":"股市必读:华仁药业新发布《第八届董事会第十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662723052","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662723052?lang=zh_cn&edition=full","pubTime":"2026-08-27 07:58","pubTimestamp":1787788696,"startTime":"0","endTime":"0","summary":"关于变更董事会专门委员会名称并修订其工作制度、修订《公司章程》及公司部分制度的公告华仁药业第八届董事会第十六次会议审议通过变更董事会专门委员会名称并修订其工作制度、修订《公司章程》及公司部分制度的议案。关于董事会换届选举的公告华仁药业第八届董事会任期届满,进行换届选举。独立董事候选人需经深交所审核无异议后方可提交股东大会表决。现任董事会成员在新一届董事会就任前继续履职。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700014517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732281","title":"华仁药业:截至2026年8月20日,公司股东总户数约为3.99万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732281","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662732281?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:48","pubTimestamp":1787662105,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月20日A股股东人数是多少?谢谢华仁药业回复:您好!截至2026年8月20日,公司股东总户数约为3.99万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500047165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169932","title":"股市必读:华仁药业(300110)8月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169932?lang=zh_cn&edition=full","pubTime":"2026-08-14 00:55","pubTimestamp":1786640110,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘,华仁药业报收于3.01元,上涨3.44%,换手率6.04%,成交量71.38万手,成交额2.14亿元。董秘最新回复投资者: 为什么多少年都走的这么纠结,无人问津,欠款还能收回吗?内控方面,公司严格按照国资监管相关规章制度、上市公司治理规则开展经营管理工作,各项决策、内控及经营管理流程同步遵循国资管理规范与上市公司监管要求。当日关注点交易信息汇总:8月13日主力资金净流入1925.05万元,占总成交额9.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152471","title":"华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659152471?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:48","pubTimestamp":1786625299,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止到7月31日公司股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年7月31日,公司股东总户数约为3.94万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300037319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657452106","title":"股市必读:华仁药业(300110)8月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657452106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657452106?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:53","pubTimestamp":1785952392,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,华仁药业报收于2.7元,下跌1.46%,换手率1.75%,成交量20.7万手,成交额5607.71万元。董秘最新回复投资者: 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。谢谢董秘: 您好,截至2026年7月31日,公司股东总户数约为3.94万户。交易信息汇总资金流向8月5日主力资金净流出306.93万元,占总成交额5.47%;游资资金净流入197.18万元,占总成交额3.52%;散户资金净流入109.75万元,占总成交额1.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657154248","title":"华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657154248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657154248?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:48","pubTimestamp":1785934108,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年7月31日A股股东人数是多少?谢谢华仁药业回复:您好,截至2026年7月31日,公司股东总户数约为3.94万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500041197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343221","title":"股市必读:华仁药业新发布《关于收到青岛证监局对公司采取责令改正监管措施决定的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343221","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343221?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:28","pubTimestamp":1785698892,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,华仁药业报收于2.68元,上涨0.75%,换手率1.63%,成交量19.28万手,成交额5159.4万元。公司公告汇总:华仁药业于7月31日收到青岛证监局责令改正监管措施决定,涉及贸易业务内控、合同管理、工程验收、对外投资及内幕信息知情人档案等多项问题,要求30日内提交书面整改报告。青岛证监局决定对公司采取责令改正的行政监管措施,要求公司30日内提交书面整改报告,并对公司治理、内部控制、追责问责等方面提出整改要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655350523","title":"华仁药业被责令改正,涉内控等违规","url":"https://stock-news.laohu8.com/highlight/detail?id=2655350523","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655350523?lang=zh_cn&edition=full","pubTime":"2026-07-31 18:38","pubTimestamp":1785494306,"startTime":"0","endTime":"0","summary":"蓝鲸新闻7月31日讯,近日,青岛证监局发布行政监管措施决定书,剑指华仁药业股份有限公司。决定书显示,华仁药业存在以下情形:贸易业务内部控制机制不健全、内部制度执行不到位、合同未全面履行或监控不当;个别销售业务缺少书面合同,个别子公司合同签署不规范;个别工程项目竣工验收报审表不完整;个别对外投资管理不规范;部分知情人未对内幕信息知情人档案表进行确认等。以上行为违反了《企业内部控制基本规范》《上市公司治理准则》《企业内部控制应用指引》《关于上市公司内幕信息知情人登记管理制度的规定》的相关规定。针对上述违法行为,青岛证监局对华仁药业采取责令改正的行政监管措施。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785491569003022820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["300110","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655332851","title":"华仁药业的“双重困局”:旧账未清、新诉重审,资产缩水近半暴露内控危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2655332851","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655332851?lang=zh_cn&edition=full","pubTime":"2026-07-31 13:58","pubTimestamp":1785477480,"startTime":"0","endTime":"0","summary":"旧账未清、新诉缠身,华仁药业的修复逻辑正遭遇严峻考验。02股权纠纷发回重审:并购后遗症叠加,管理层问责缺位与应收账款旧账并行的,是一桩延续多年的股权收购纠纷。2021年,子公司曲江华仁收购安徽恒星制药100%股权,交易对手随后起诉要求支付2.56亿元业绩承诺尾款及违约金,合计2.84亿元,并要求上市公司承担连带责任。曲江华仁则反诉请求撤销协议、返还5.44亿元转让款及资金占用费。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-07-31/doc-iniksnxm4558734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655898737","title":"华仁药业:上半年业绩情况请关注公司计划于2026年8月27日披露的2026年半年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2655898737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655898737?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:48","pubTimestamp":1785329321,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问:口口声声提升业绩回馈投资者,上半年业绩如何?为什么没预告?华仁药业回复:您好,规则未强制要求创业板上市公司发布半年度业绩预告,上半年业绩情况请您关注公司计划于2026年8月27日披露的2026年半年度报告。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900037866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654064997","title":"股市必读:华仁药业(300110)7月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2654064997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654064997?lang=zh_cn&edition=full","pubTime":"2026-07-27 02:10","pubTimestamp":1785089425,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,华仁药业报收于2.59元,下跌3.72%,换手率1.91%,成交量22.56万手,成交额5932.96万元。董秘最新回复投资者: 你们现在对国药药材提起诉讼是不是太晚了?公司将持续压实各级管理人员经营主体责任,切实维护全体股东合法权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700001033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653827290","title":"华仁药业:持续推进相关应收款项追偿","url":"https://stock-news.laohu8.com/highlight/detail?id=2653827290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653827290?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:48","pubTimestamp":1784897310,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业07月24日在投资者关系平台上答复投资者关心的问题。公司将持续压实各级管理人员经营主体责任,切实维护全体股东合法权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653717082","title":"华仁药业:积极布局饮料、化妆品、健康饮品等大健康产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2653717082","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653717082?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:48","pubTimestamp":1784897305,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问:饮料,化妆品为什么几年的销量都占比很小,你们以怎样的方式在销售工作有没有专业队伍还是在闭门造车?华仁药业回复:您好,公司积极布局饮料、化妆品、健康饮品等大健康产品线,主要采用线上线下相结合的模式开展销售。该系列产品目前销售收入占比还较小,后续公司将加强品牌建设和渠道建设,持续推进大健康产品线上、线下销售渠道的开发与推广。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653723832","title":"华仁药业:截至2026年7月20日,公司股东总户数约为3.96万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653723832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653723832?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:00","pubTimestamp":1784811628,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年7月20日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年7月20日,公司股东总户数约为3.96万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300045885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653723874","title":"华仁药业:公司将基于最大化挽回损失的原则,持续积极跟进债务化解进度","url":"https://stock-news.laohu8.com/highlight/detail?id=2653723874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653723874?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:00","pubTimestamp":1784811627,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问:公司是否对国药药材提起诉讼?不是说最小损失原则减少损失化解债务吗?是否可能收回,对方有执行标的吗?华仁药业回复:尊敬的投资者您好,公司将基于最大化挽回损失的原则,持续积极跟进债务化解进度。公司将结合国药药材履约情况,积极合理配合利用司法手段,最大限度确保债务化解执行质量及效果,最大程度挽回损失,最大程度维护公司及全体股东的合法权益。感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300045882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428204","title":"华仁药业:已将常态化梳理应收款项、加快应收处置回款、持续优化资产结构等纳入重点工作安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651428204?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:51","pubTimestamp":1784206283,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业07月15日在投资者关系平台上答复投资者关心的问题。请问管理层在制定市值管理方案时,有无将\"加快诉讼回款、加大坏账核销/冲回、优化资产质量\"作为提升估值的重要手段并向市场主动披露相关规划?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600038080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651459532","title":"华仁药业(300110)披露重大诉讼进展公告,7月15日股价上涨1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651459532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651459532?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:31","pubTimestamp":1784107917,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘,华仁药业报收于2.82元,较前一交易日上涨1.81%,最新总市值为33.34亿元。华仁药业于近日披露《关于重大诉讼的进展公告》。本案系陕西省高级人民法院指令西安市中级人民法院重新立案审理,案号为陕01民初208号,目前尚未开庭。此前相关案件已被驳回起诉,原告上诉后获指令继续审理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651510638","title":"华仁药业:关于股份回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2651510638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651510638?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:53","pubTimestamp":1784033594,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问:别的公司都在回购你们为什么不回购?请解释一下具体原因股价很高吗?你们为什么会在4块8收购,为什么不回购?华仁药业回复:尊敬的投资者您好,关于股份回购计划,公司将根据市场情况、财务状况及发展战略等多方面因素进行综合考虑,作出科学合理的决策,维护广大投资者利益。如有相关回购计划,公司将严格遵守相关规定,及时履行信息披露义务。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400046429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651063811","title":"华仁药业:截至2026年7月10日,公司股东总户数约为3.90万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651063811","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651063811?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:53","pubTimestamp":1784033592,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年7月10日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年7月10日,公司股东总户数约为3.90万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400046424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788016747063,"stockEarnings":[{"period":"1week","weight":0.035},{"period":"1month","weight":0.0963},{"period":"3month","weight":0.0571},{"period":"6month","weight":-0.1003},{"period":"1year","weight":-0.1294},{"period":"ytd","weight":-0.0603}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0323},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0283},{"period":"ytd","weight":-0.0042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华仁药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39900人(较上一季度增加1.01%)","perCapita":"29609股","listingDate":"2010-08-25","address":"山东省青岛市崂山区高科技工业园株洲路187号","registeredCapital":"118221万元","survey":" 华仁药业股份有限公司的主营业务是原料药、制剂、医疗器械、医用包材、大健康产品的研发、生产、销售。公司的主要产品是基础输液、腹膜透析液、小容量注射剂、治疗性输液、片剂、胶囊剂、散剂、颗粒剂、医疗器械、配套医用包材、大健康产品、原料药。公司先后获得“全国AAA级信用企业”、“国家知识产权优势/示范企业”、“中国化学制药行业工业企业综合实力百强”、“中国医药工业百强”、“山东省质量管理奖”、“山东省高端品牌培育企业”、“‘品质鲁药’建设示范企业”等系列荣誉。","listedPrice":13.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华仁药业,300110,华仁药业股票,华仁药业股票老虎,华仁药业股票老虎国际,华仁药业行情,华仁药业股票行情,华仁药业股价,华仁药业股市,华仁药业股票价格,华仁药业股票交易,华仁药业股票购买,华仁药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}